Clinical study of lipo prostaglandin E1 in treatment of severe acute pancreatitis

xie shouyong,huang zongwen,chen guangyuan,xia qing

DOI: https://doi.org/10.3969/j.issn.1672-3511.2010.10.033

2010-01-01

Abstract:Objective To investigate the efficacy of lipo prostaglandin E1(Lipo PGE1) on patients with severe acute pancreatitis with a randomized open-label and controlled trial.Method 74 patients fulfilling the Bangkok meeting criteria for severe acute pancreatitis,within 72 hours of the onset of the symptoms were randomized equally to Lipo PGE1 treated group and controlled group.Both groups accepted the integrated TCM-WM treatment non-surgically,while the Lipo PGE1 group received 20μg of Lipo PGE1 by intravenous injection once daily for 7 days additionally.Laboratory parameters,conditions of disease and therapeutic effect indexes,including occurrence of organic dysfunction,APACHⅡscores,Ranson scores,CTSI(CT Severe Index) scores,SOFA(Sequential organ failure assessment) scores,local complications and mortality between the two groups were compared.The length of hospitalization and need for surgery were also compared.Results 71 patients completed the study protocol(36 treated,35 controlled).The distribution of variable at baseline describing gender,age,etiology,time from onset of the symptoms to hospital,APACHⅡscores,Ranson scores,SOFA scores,CTSI scores were similar among patients in both groups.There was no significant difference in SOFA scores between Lipo PGE1 group and controlled group neither on day 3 or on day 8.APACHⅡscores were reduced in Lipo PGE1 group both on day 3 and on day 8.The occurrence of organic dysfunction was similar in both groups.Pseudocysts occurred in 11/35(31.4%) patients in controlled group and in 7/36(19.4%) patients in PGE1 group;pancreatic infection developed in 5 and 2 patients respectively;the overall local complications(pancreatic necrosis was not included) occurred in 16/35(45.7%) in controlled group and in 9/36(25%) in Lipo PGE1 group(P=0.068).The length of hospitalization was 27 days(median) in controlled group and 24.5 days in Lipo PGE1 group.6 patients(17.1%) in controlled group and 3 patients(8.3%) in Lipo PGE1 group got surgery.4 patients in controlled group and 2 patients in Lipo PGE1 group died of severe acute pancreatitis(P=0.323). Conclusion It’s concluded that the application of Lipo PGE1 to patients with severe acute pancreatitis may improve their conditions and decrease local complications based on integrated Traditional Chinese Medicine and West Medicine,but this was not statistically significant.So it should be verified by enlarging sample size.